EUVIMED · CrossrefZeitschrift
World Allergy Organization Journal
ISSN 1939-4551 · Elsevier BV
Neueste Artikel
Clinical utility of Oriton IgE CHEMIPHAR™ for predicting skin prick test positivity in patients with allergic airway diseases
Executive Summary of the 2025 World Allergy Organization Guidelines for Hereditary Angioedema
Olive allergens under the microscope: Ole e 7 and Ole e 9 sensitization does not increase symptom severity or adverse reactions to subcutaneous allergen immunotherapy
Landscape of hereditary angioedema in China: A multicenter cross-sectional questionnaire survey
Biologic therapies for atopic diseases during pregnancy: A World Allergy Organization survey
Fungal sensitization in China: Regional heterogeneity, diagnostic gaps, and implications for standardized allergy assessment
Overdiagnosis and underdiagnosis in mast cell activation syndrome: The diagnostic specificity paradox
Sleep quality and obstructive sleep apnoea risk in chronic spontaneous urticaria: Methodological and reporting considerations
Small airway dysfunction as a functional barrier to spirometry-defined clinical remission in severe asthma treated with biologic therapies
Sleep quality, disturbance and the prevalence of obstructive sleep apnoea in chronic spontaneous urticaria and associated risk factors
Mast cell activation syndrome: Global perspectives from a World Allergy Organization survey on knowledge, diagnosis, and access to care
World Allergy Organization (WAO) Consensus on the use and practice of precautionary allergen labelling: The international ACT-UP! e-Delphi
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials
Olfactory mucosal inflammation and barrier disruption correlate with perceived CRSwNP-associated olfactory dysfunction
Trends in the prevalence of childhood allergic diseases in Japan: Comparison of surveys conducted in 1982, 1992, 2002, 2012, and 2022 (WJSAAC phase I–V)
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities
Androgenetic alopecia risk in allergic rhinitis: A cohort study of immune and antihistamine effects
Overview of allergic disease: Anaphylaxis – WAO White Book on Allergy 2026 – 2.11
Nature prescription for patients with chronic respiratory diseases
Dupilumab in real-world pediatric asthma: Enhanced control and quality of life for children and caregivers
Developing a patient journey map to improve care and experience in Chinese patients with hereditary angioedema
Increased glucose transporter 1 contributes to epithelial barrier dysfunction in allergic rhinitis
The definition of asthma remission in children: A scoping review by the WAO Paediatric Asthma Committee
Messenger RNA vaccines in the prevention of allergic diseases
Hereditary angioedema: A national investigation of associated comorbidities and surgical procedures
Improvement of the therapeutic management of allergic patients in Europe – An expert think tank's position paper on allergen immunotherapy
Association between circulating thyroperoxidase (TPO), anti-TPO IgE, anti-TPO IgG, and different clinical outcomes in chronic urticaria: A hypothesis-generating study
Increased LOXL2 facilitates tissue remodeling in eosinophilic chronic rhinosinusitis with nasal polyps
Molecular allergens drive risk stratification and immunotherapy in Hymenoptera venom allergy
Drug hypersensitivity reactions in children in clinical practice: A WAO Statement
EUVIMED